Centre Hospitalier Arras
13
3
4
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.7%
1 terminated/withdrawn out of 13 trials
85.7%
-0.8% vs industry average
15%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock?
Role: collaborator
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
Role: collaborator
Ventilator Settings for Bronchoscopy During Mechanical Ventilation: a Randomized Controlled Study
Role: lead
Air vs. Cutaneous Control Mode for Preterm Infants ≤ 32 WG in Incubators: Impact on Body Growth and Morbidity
Role: collaborator
Predictability of the Clinical Global Impression Scale (CGI) in Post Immediate in Psychotraumatic Impact
Role: lead
Impact of Metformin on Leptin Transport in Cerebrospinal Fluid of Obese Patients
Role: collaborator
Evaluation of the API-VIGIE Monitoring System: Program to Reduce Emergency Visits for Severe Paroxysmal Alcoholism
Role: lead
The Multitasking Rehabilitation She Enhanced Walking Speed Compared to the Simple Post Stroke Rehabilitation Task (AVC)?
Role: collaborator
Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context
Role: lead
Under the Nose Face Mask to Prevent Facial Pressure Ulcers During NIV for Acute Hypercapnic Respiratory Failure (AHRF)
Role: lead
Changes in PPV Induced by PLR Test to Predict Fluid Responsiveness in ICU
Role: lead
Severe Obesity and Eating Habits (OSCAR)
Role: lead
Relieve the Patient's Thirst, Refresh the Mouth First (ICU-MIC)
Role: lead
All 13 trials loaded